RESUMO
The threat of criminal activity in the fisheries sector has concerned the international community for a number of years. In more recent times, the presence of organized crime in fisheries has come to the fore. In 2008, the United Nations General Assembly asked all states to contribute to increasing our understanding the connection between illegal fishing and transnational organized crime at sea. Policy-makers, researchers and members of civil society are increasing their knowledge of the dynamics and destructiveness of the blue shadow economy and the role of organized crime within this economy. Anecdotal, scientific and example-based evidence of the various manifestations of organized crime in fisheries, its widespread adverse impacts on economies, societies and the environment globally and its potential security consequences is now publicly available. Here we present the current state of knowledge on organized crime in the fisheries sector. We show how the many facets of organized crime in this sector, including fraud, drug trafficking and forced labour, hinder progress towards the development of a sustainable ocean economy. With reference to worldwide promising practices, we highlight practical opportunities for action to address the problem. We emphasize the need for a shared understanding of the challenge and for the implementation of intelligence-led, skills-based cooperative law enforcement action at a global level and a community-based approach for targeting organized crime in the supply chain of organized criminal networks at a local level, facilitated by legislative frameworks and increased transparency.
Assuntos
Crime/economia , Política Ambiental/economia , Política Ambiental/legislação & jurisprudência , Pesqueiros/economia , Oceanos e Mares , Desenvolvimento Sustentável/economia , Desenvolvimento Sustentável/legislação & jurisprudência , Animais , Tráfico de Drogas/economia , Fraude/economia , Tráfico de Pessoas/economia , Humanos , Internacionalidade , Impostos/economiaRESUMO
After raising more than $700 million, Elizabeth Holmes, the founder and chief executive officer of a healthcare startup once valued at $10 billion, was found guilty on four charges of defrauding investors. Founded in 2003, Theranos Inc. was a privately held corporation that aimed to disrupt the diagnostics industry with rapid, direct-to-consumer laboratory testing using only "a drop of blood" and the company's patented Nanotainer technology. By exploiting gaps in regulatory policy, Theranos brought its panel of laboratory tests to patients without pre-market review or validation from peer-reviewed scientific research. Investigations into Theranos' dubious operations and inaccurate test results exposed the failed venture which had squandered millions of dollars. Theranos affected the lives and health of patients further disrupting an already tenuous relationship between healthcare and the public - the importance of which cannot be understated in the setting of the COVID-19 pandemic. As medical systems address a national public health crisis and pervasive structural inequities, we must align stakeholder incentives between industry and academic biomedical innovation to rebuild trust with our patients.
Assuntos
COVID-19/diagnóstico , Técnicas de Laboratório Clínico/métodos , Fraude/prevenção & controle , Pandemias , COVID-19/epidemiologia , Técnicas de Laboratório Clínico/ética , Técnicas de Laboratório Clínico/normas , Atenção à Saúde , Fraude/economia , Fraude/legislação & jurisprudência , Fraude/tendências , Humanos , Nanoestruturas/normas , Nanotecnologia/economia , Nanotecnologia/normas , Saúde Pública , Estados UnidosAssuntos
Conflito de Interesses , Fraude , Humanos , Conflito de Interesses/economia , Fraude/economiaRESUMO
Landmark reports from reputable sources have concluded that the United States wastes hundreds of billions of dollars every year on medical care that does not improve health outcomes. While there is widespread agreement over how wasteful medical care spending is defined, there is no consensus on its magnitude or categories. A shared understanding of the magnitude and components of the issue may aid in systematically reducing wasteful spending and creating opportunities for these funds to improve public health.To this end, we performed a review and crosswalk analysis of the literature to retrieve comprehensive estimates of wasteful medical care spending. We abstracted each source's definitions, categories of waste, and associated dollar amounts. We synthesized and reclassified waste into 6 categories: clinical inefficiencies, missed prevention opportunities, overuse, administrative waste, excessive prices, and fraud and abuse.Aggregate estimates of waste varied from $600 billion to more than $1.9 trillion per year, or roughly $1800 to $5700 per person per year. Wider recognition by public health stakeholders of the human and economic costs of medical waste has the potential to catalyze health system transformation.
Assuntos
Gastos em Saúde/estatística & dados numéricos , Uso Excessivo dos Serviços de Saúde/economia , Eficiência Organizacional , Fraude/economia , Custos de Cuidados de Saúde/estatística & dados numéricos , Humanos , Prevenção Primária/economia , Estados UnidosRESUMO
BACKGROUND: The dynamic intersection of a pluralistic health system, large informal sector, and poor regulatory environment have provided conditions favourable for 'corruption' in the LMICs of south and south-east Asia region. 'Corruption' works to undermine the UHC goals of achieving equity, quality, and responsiveness including financial protection, especially while delivering frontline health care services. This scoping review examines current situation regarding health sector corruption at frontlines of service delivery in this region, related policy perspectives, and alternative strategies currently being tested to address this pervasive phenomenon. METHODS: A scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) was conducted, using three search engines i.e., PubMed, SCOPUS and Google Scholar. A total of 15 articles and documents on corruption and 18 on governance were selected for analysis. A PRISMA extension for Scoping Reviews (PRISMA-ScR) checklist was filled-in to complete this report. Data were extracted using a pre-designed template and analysed by 'mixed studies review' method. RESULTS: Common types of corruption like informal payments, bribery and absenteeism identified in the review have largely financial factors as the underlying cause. Poor salary and benefits, poor incentives and motivation, and poor governance have a damaging impact on health outcomes and the quality of health care services. These result in high out-of-pocket expenditure, erosion of trust in the system, and reduced service utilization. Implementing regulations remain constrained not only due to lack of institutional capacity but also political commitment. Lack of good governance encourage frontline health care providers to bend the rules of law and make centrally designed anti-corruption measures largely in-effective. Alternatively, a few bottom-up community-engaged interventions have been tested showing promising results. The challenge is to scale up the successful ones for measurable impact. CONCLUSIONS: Corruption and lack of good governance in these countries undermine the delivery of quality essential health care services in an equitable manner, make it costly for the poor and disadvantaged, and results in poor health outcomes. Traditional measures to combat corruption have largely been ineffective, necessitating the need for innovative thinking if UHC is to be achieved by 2030.
Assuntos
Fraude/economia , Setor de Assistência à Saúde/organização & administração , Política de Saúde/economia , Setor Privado/economia , Setor Público/economia , Ásia , Países em Desenvolvimento , Governo , Pessoal de Saúde/economia , Humanos , Renda , Assistência Médica/economia , Características de ResidênciaRESUMO
BACKGROUND: Illicit financial flows (IFFs) drain domestic resources with harmful social effects, especially in countries which are too poor to mobilise the revenues required to finance the provision of essential public goods and services. In this context, this article empirically examined the association between IFFs and the provision of essential health services in low- and middle-income countries. METHODS: Firstly, a set of indicators was selected to represent the overall coverage of essential health services at the country level. Next, a linear multivariate regression model was specified and estimated for each indicator using cross-sectional data for 72 countries for the period 2008-2013. RESULTS: After controlling for other relevant factors, the main result of the regression analysis was that an annual 1 percentage point (p.p.) increase in the ratio of IFFs to total trade was associated with a 0.46 p.p. decrease in the level of family planning coverage, a 0.31 p.p. decrease in the percentage of women receiving antenatal care, and a 0.32 p.p. decrease in the level of child vaccination coverage rates. CONCLUSIONS: These findings suggest that, for the whole sample of countries considered, at least 3.9 million women and 190,000 children may not receive these basic health care interventions in the future as a consequence of a 1 p.p. increase in the ratio of IFFs to total trade. Moreover, given that family planning, reproductive health, and child immunisation are foundational components of health and long-term development in poor countries, the findings show that IFFs could be undermining the achievement of the 2030 Agenda for Sustainable Development.
Assuntos
Países em Desenvolvimento/economia , Fraude/economia , Governo , Serviços de Saúde Materna , Criança , Estudos Transversais , Serviços de Planejamento Familiar/economia , Feminino , Saúde Global , Humanos , Programas de Imunização/economia , Serviços de Saúde Materna/economia , Serviços de Saúde Materna/provisão & distribuição , GravidezRESUMO
There have been inconsistent results regarding whether older adults are more vulnerable to fraud than younger adults. The two main goals of this study were to investigate the claim that there is an age-related vulnerability to fraud and to examine whether emotional intelligence (EI) may be associated with fraud susceptibility. Participants (N = 281; 18-82 years; M = 53.4) were recruited via Amazon's Mechanical Turk and completed measures of EI, decision-making, and scam susceptibility. Participants who scored higher on "ability" EI were less susceptible to scams. The "younger" group (M = 2.50, SD = 1.06) was more susceptible to scams than the "older" group, p <.001, d = 0.56, while the "older" group (M = 4.64, SD = 1.52) reported the scams as being more risky than the "younger" group, p =.002, d = 0.37. "Older" participants were more sensitive to risk, less susceptible to persuasion, and had higher than average emotional understanding. Emotional understanding was found to be a partial mediator for age-related differences in scam susceptibility and susceptibility to persuasion.
Assuntos
Tomada de Decisões , Inteligência Emocional , Fraude/economia , Investimentos em Saúde/economia , Adulto , Fatores Etários , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de ProteçãoRESUMO
Senior financial exploitation (FE) is prevalent and harmful. Its often insidious nature and co-occurrence with other forms of mistreatment make detection and substantiation challenging. A secondary data analysis of N = 8,800 Adult Protective Services substantiated senior mistreatment cases, using machine learning algorithms, was conducted to determine when pure FE versus hybrid FE was occurring. FE represented N = 2514 (29%) of the cases with 78% being pure FE. Victim suicidal ideation and threatening behaviors, injuries, drug paraphernalia, contentious relationships, caregiver stress, and burnout and victims needing assistance were most important for differentiating FE vs non-FE-related mistreatment. The inability to afford housing, medications, food, and medical care as well as victims suffering from intellectual disability disorder(s) predicted hybrid FE. This study distinguishes socioecological factors strongly associated with the presence of FE during protective service investigations. These findings support existing and new indicators of FE and could inform protective service investigation practices.
Assuntos
Ciência de Dados/métodos , Abuso de Idosos/economia , Fraude/economia , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Feminino , Humanos , Masculino , Fatores de Risco , Fatores Socioeconômicos , Estados UnidosRESUMO
Plans to optimize health care in the United States highlight the high cost but rarely explore opportunities for redirecting resources within the existing system to increase access to care while lowering spending. This analysis indicates that, of the total national health care expenditures of $3.21 trillion in 2015, only $1.4 trillion to $2.86 trillion was used to provide care to patients. This range was reached by the subtraction of excess spending in 7 categories. Thus, many opportunities exist to repurpose wasted expenditures to increase access to health care without the need for additional funding.
Assuntos
Atenção à Saúde/economia , Atenção à Saúde/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Qualidade da Assistência à Saúde/economia , Redução de Custos , Análise Custo-Benefício , Infecção Hospitalar/economia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/terapia , Atenção à Saúde/organização & administração , Eficiência Organizacional/economia , Feminino , Fraude/economia , Fraude/estatística & dados numéricos , Custos de Cuidados de Saúde/estatística & dados numéricos , Mau Uso de Serviços de Saúde/economia , Mau Uso de Serviços de Saúde/estatística & dados numéricos , Humanos , Cobertura do Seguro/economia , Cobertura do Seguro/estatística & dados numéricos , Masculino , Erros Médicos/economia , Erros Médicos/estatística & dados numéricos , Qualidade da Assistência à Saúde/estatística & dados numéricos , Estados Unidos/epidemiologiaRESUMO
The Supplemental Nutrition Assistance Program (SNAP) provides funding to low-income households to purchase food at participating stores. The goals of the program include reducing hunger, improving nutrition, and strengthening the US food system. These are interrelated, as food access and choice depend on availability.SNAP generates data that could be useful for program evaluation and evidence-based policymaking to reach public health goals. However, the US Department of Agriculture (USDA) does not collect or disclose all SNAP-related data. In particular, the USDA does not systematically collect food expenditure data, and although it does collect transaction (sales) and redemption data (the amount retailers are reimbursed through SNAP), it does not release these data at the store level.In 2018, Congress quietly changed the law to prohibit the USDA from disclosing store-level transaction and redemption data, and in 2019, the US Supreme Court blocked disclosure of these data. These federal proceedings can inform the outcome of additional efforts to disclose SNAP-related data, as well as future research and policy evaluation to support improved public health outcomes for SNAP beneficiaries.
Assuntos
Revelação/normas , Assistência Alimentar/organização & administração , Assistência Alimentar/estatística & dados numéricos , Abastecimento de Alimentos/métodos , Abastecimento de Alimentos/estatística & dados numéricos , Revelação/legislação & jurisprudência , Assistência Alimentar/legislação & jurisprudência , Assistência Alimentar/normas , Abastecimento de Alimentos/legislação & jurisprudência , Fraude/economia , Fraude/estatística & dados numéricos , Humanos , Estados Unidos , United States Department of Agriculture/organização & administraçãoAssuntos
Fraude/estatística & dados numéricos , Publicações Periódicas como Assunto/estatística & dados numéricos , Publicações Periódicas como Assunto/normas , Editoração/estatística & dados numéricos , Editoração/normas , Fraude/economia , Internet , Revisão da Pesquisa por Pares/normas , Editoração/economia , Reprodutibilidade dos TestesRESUMO
Predatory publishing is an exploitative fraudulent open-access publishing model that applies charges under the pretense of legitimate publishing operations without actually providing the editorial services associated with legitimate journals. The aim of this study was to analyze this phenomenon in the field of anesthesiology and related specialties (intensive care, critical and respiratory medicine, pain medicine, and emergency care). Two authors independently surveyed a freely accessible, constantly updated version of the original Beall lists of potential, possible, or probable predatory publishers and standalone journals. We identified 212 journals from 83 publishers, and the total number of published articles was 12,871. The reported location of most publishers was in the United States. In 43% of cases (37/84), the reported location was judged as "unreliable" after being checked using the 3-dimensional view in Google Maps. Six journals were indexed in PubMed. Although 6 journals were declared to be indexed in the Directory of Open Access Journals, none were actually registered. The median article processing charge was 634.5 US dollars (interquartile range, 275-1005 US dollars). Several journals reported false indexing/registration in the Committee on Publication Ethics and International Committee of Medical Journal Editors registries and Google Scholar. Only 32% (67/212) reported the name of the editor-in-chief. Rules for ethics/scientific misconduct were reported in only 24% of cases (50/212). In conclusion, potential or probable predatory open-access publishers and journals are widely present in the broad field of anesthesiology and related specialties. Researchers should carefully check journals' reported information, including location, editorial board, indexing, and rules for ethics when submitting their manuscripts to open-access journals.
Assuntos
Anestesiologia/normas , Pesquisa Biomédica/normas , Políticas Editoriais , Fraude , Publicação de Acesso Aberto/normas , Revisão da Pesquisa por Pares/normas , Publicações Periódicas como Assunto/normas , Anestesiologia/economia , Anestesiologia/ética , Bibliometria , Pesquisa Biomédica/economia , Pesquisa Biomédica/ética , Fraude/economia , Fraude/ética , Humanos , Publicação de Acesso Aberto/economia , Publicação de Acesso Aberto/ética , Revisão da Pesquisa por Pares/ética , Publicações Periódicas como Assunto/economia , Publicações Periódicas como Assunto/éticaRESUMO
Honesty is a fundamental pillar for cooperation in human societies and thus for their economic welfare. However, humans do not always act in an honest way. Here, we examine how insurance coverage affects the degree of honesty in credence goods markets. Such markets are plagued by strong incentives for fraudulent behavior of sellers, resulting in estimated annual costs of billions of dollars to customers and the society as a whole. Prime examples of credence goods are all kinds of repair services, the provision of medical treatments, the sale of software programs, and the provision of taxi rides in unfamiliar cities. We examine in a natural field experiment how computer repair shops take advantage of customers' insurance for repair costs. In a control treatment, the average repair price is about EUR 70, whereas the repair bill increases by more than 80% when the service provider is informed that an insurance would reimburse the bill. Our design allows decomposing the sources of this economically impressive difference, showing that it is mainly due to the overprovision of parts and overcharging of working time. A survey among repair shops shows that the higher bills are mainly ascribed to insured customers being less likely to be concerned about minimizing costs because a third party (the insurer) pays the bill. Overall, our results strongly suggest that insurance coverage greatly increases the extent of dishonesty in important sectors of the economy with potentially huge costs to customers and whole economies.
Assuntos
Fraude/economia , Cobertura do SeguroRESUMO
Importance: The United States spends more on health care than any other country, with costs approaching 18% of the gross domestic product (GDP). Prior studies estimated that approximately 30% of health care spending may be considered waste. Despite efforts to reduce overtreatment, improve care, and address overpayment, it is likely that substantial waste in US health care spending remains. Objectives: To estimate current levels of waste in the US health care system in 6 previously developed domains and to report estimates of potential savings for each domain. Evidence: A search of peer-reviewed and "gray" literature from January 2012 to May 2019 focused on the 6 waste domains previously identified by the Institute of Medicine and Berwick and Hackbarth: failure of care delivery, failure of care coordination, overtreatment or low-value care, pricing failure, fraud and abuse, and administrative complexity. For each domain, available estimates of waste-related costs and data from interventions shown to reduce waste-related costs were recorded, converted to annual estimates in 2019 dollars for national populations when necessary, and combined into ranges or summed as appropriate. Findings: The review yielded 71 estimates from 54 unique peer-reviewed publications, government-based reports, and reports from the gray literature. Computations yielded the following estimated ranges of total annual cost of waste: failure of care delivery, $102.4 billion to $165.7 billion; failure of care coordination, $27.2 billion to $78.2 billion; overtreatment or low-value care, $75.7 billion to $101.2 billion; pricing failure, $230.7 billion to $240.5 billion; fraud and abuse, $58.5 billion to $83.9 billion; and administrative complexity, $265.6 billion. The estimated annual savings from measures to eliminate waste were as follows: failure of care delivery, $44.4 billion to $97.3 billion; failure of care coordination, $29.6 billion to $38.2 billion; overtreatment or low-value care, $12.8 billion to $28.6 billion; pricing failure, $81.4 billion to $91.2 billion; and fraud and abuse, $22.8 billion to $30.8 billion. No studies were identified that focused on interventions targeting administrative complexity. The estimated total annual costs of waste were $760 billion to $935 billion and savings from interventions that address waste were $191 billion to $286 billion. Conclusions and Relevance: In this review based on 6 previously identified domains of health care waste, the estimated cost of waste in the US health care system ranged from $760 billion to $935 billion, accounting for approximately 25% of total health care spending, and the projected potential savings from interventions that reduce waste, excluding savings from administrative complexity, ranged from $191 billion to $286 billion, representing a potential 25% reduction in the total cost of waste. Implementation of effective measures to eliminate waste represents an opportunity reduce the continued increases in US health care expenditures.
Assuntos
Redução de Custos/economia , Atenção à Saúde/economia , Gastos em Saúde , Técnicas de Laboratório Clínico/economia , Atenção à Saúde/organização & administração , Custos de Medicamentos , Fraude/economia , Humanos , Uso Excessivo dos Serviços de Saúde/economia , Uso Excessivo dos Serviços de Saúde/prevenção & controle , Visita a Consultório Médico/economia , Falha de Tratamento , Estados Unidos , Procedimentos Desnecessários/economiaAssuntos
Vítimas de Crime , Fraude/prevenção & controle , Publicações Periódicas como Assunto/ética , Publicações Periódicas como Assunto/normas , Pesquisadores/educação , Consultores , Vítimas de Crime/economia , Publicações Duplicadas como Assunto , Políticas Editoriais , Correio Eletrônico , Fraude/economia , Internet , Publicação de Acesso Aberto/economia , Publicação de Acesso Aberto/ética , Publicação de Acesso Aberto/normas , Publicações Periódicas como Assunto/economia , Pesquisadores/economiaAssuntos
Políticas Editoriais , Fraude/estatística & dados numéricos , Publicações Periódicas como Assunto/ética , Publicações Periódicas como Assunto/estatística & dados numéricos , Pesquisadores , Pesquisa , Fraude/economia , Publicações Periódicas como Assunto/economia , Pesquisa/economia , Pesquisa/normas , Pesquisadores/economia , Pesquisadores/normasAssuntos
Fraude/prevenção & controle , Pesquisadores/ética , Pesquisa/normas , Má Conduta Científica , Gravação de Videoteipe , Animais , Animais Selvagens , Dióxido de Carbono/efeitos adversos , Mudança Climática , Recifes de Corais , Peixes/fisiologia , Fraude/economia , Motivação , Revisão da Pesquisa por Pares/métodos , Revisão da Pesquisa por Pares/normas , Reprodutibilidade dos Testes , Pesquisa/economia , Ciências Sociais/métodos , Ciências Sociais/normas , ConfiançaAssuntos
Medicamentos Falsificados/provisão & distribuição , Fraude/legislação & jurisprudência , Fraude/prevenção & controle , Indicadores e Reagentes/provisão & distribuição , Indicadores e Reagentes/normas , Pesquisa , Anticorpos/química , Anticorpos/imunologia , Especificidade de Anticorpos , China , Comércio/ética , Comércio/normas , Medicamentos Falsificados/química , Medicamentos Falsificados/economia , Fraude/economia , Humanos , Indicadores e Reagentes/química , Indicadores e Reagentes/economia , Controle de Qualidade , Reciclagem , Reprodutibilidade dos Testes , Pesquisa/normas , Pesquisadores/educação , IncertezaRESUMO
OBJECTIVES: On the basis of the experience of the Netherlands, this critical commentary will argue why activity-based funding (ABF) in mental health care is a disastrous path that Australia should not take. CONCLUSIONS: ABF leads to an exponential growth in health care spending as it encourages diagnostic inflation and overproductivity. It also leads to fraud and an increased bureaucracy that goes hand in hand with demoralisation among health workers. And finally, the increasing treatment claims leads to the reintroduction of productivity limitations, waiting lists and ultimately austerity measures in order to halt the untamed growth of spending.